Testing

Search documents
Psychemedics Releases 2025 Workforce Insights Report
Globenewswire· 2025-06-16 13:00
Synthetic Drug Threats and Legalization Risks Shape a New Era for Workplace SafetyDALLAS, June 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, today announced the release of its second annual Workforce Insights Report, providing a comprehensive look at the evolving drug landscape and its impact on workplace safety, hiring practices, and employer risk. The 2025 Psychemedics Insights Report draws from the largest proprietary database of hair drug test ...
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
Globenewswire· 2025-06-13 20:22
Core Viewpoint - 23andMe has entered into a definitive agreement to sell substantially all of its assets to TTAM Research Institute for $305 million, following a competitive bidding process that included Regeneron Pharmaceuticals as a backup bidder [2][3]. Group 1: Transaction Details - The sale includes the Personal Genome Service (PGS), Research Services business lines, and Lemonaid Health business [2]. - The transaction is subject to approval by the U.S. Bankruptcy Court, with a hearing scheduled for June 17, 2025 [7]. - The agreement with TTAM will replace a previously announced acquisition agreement with Regeneron for $256 million [5]. Group 2: Privacy and Consumer Protections - TTAM has committed to comply with 23andMe's privacy policies and applicable laws, ensuring customer data is processed according to existing consents and privacy statements [4]. - Additional consumer protections include honoring customer rights to delete accounts and genetic data, notifying customers before closing, and establishing a Consumer Privacy Advisory Board within 90 days [6]. - TTAM will offer two years of free identity theft monitoring to customers and will continue to allow de-identified data to be used for research [6].
Battery Cyclers Market Trends, Forecast & Competitive Landscape Report 2025, Featuring Kikusui Electronics, EnerSys, Arbin Instruments, MTI Instruments, BIT BUDDY, Neware Technology and more
GlobeNewswire News Room· 2025-06-12 10:37
Core Insights - The Battery Cyclers Market is projected to grow from USD 1.2 Billion in 2024 to USD 1.9 Billion by 2030, with a CAGR of 8.10% [1][14]. Market Drivers - The increasing adoption of electric vehicles (EVs) and renewable energy storage systems is driving demand for efficient battery testing solutions, as battery cyclers are essential for simulating real-world charge-discharge scenarios [2][6]. - The establishment of battery manufacturing facilities, especially in the Asia-Pacific region, is amplifying the demand for high-capacity and multi-channel cyclers [3]. - Advancements in battery chemistries, such as solid-state and lithium-sulfur, necessitate sophisticated testing systems, further boosting market demand [3][7]. Market Challenges - The high capital investment required for advanced battery cyclers and testing infrastructure poses a significant challenge, particularly for smaller companies and research institutions [9][10]. - Additional costs related to supporting infrastructure and maintenance increase the total cost of ownership, which can hinder innovation in emerging economies [10]. Market Trends - The integration of advanced technologies like AI, IoT, and data analytics is enhancing battery testing outcomes, enabling predictive maintenance and remote monitoring [11][12]. - Cloud-based platforms are facilitating centralized access to performance data, promoting collaboration across R&D teams and transforming battery cyclers into intelligent, networked platforms [12]. Key Market Players - Notable companies in the battery cyclers market include Kikusui Electronics, EnerSys, Arbin Instruments, MTI Instruments, National Instruments, BIT BUDDY, Neware Technology, and Zhengzhou Dazhong Machinery [16].
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
Globenewswire· 2025-06-11 12:30
SMARTOX has deployed over 50 of INBS' Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone As adoption grows in the U.S. Forensic Use Only market, INBS continues to actively pursue FDA clearance for its opiate test system for codeine. This effort aims to enable expansion into broader U.S. markets this year, including workplace drug testing, using its innovative fingerprint sweat-based testing technology. "We have partnere ...
ITRI to Roll Out Cyble 5 in APAC to Boost Water Utilities' Operations
ZACKS· 2025-06-10 15:31
Core Insights - Itron, Inc. is launching its Cyble 5 communication module in the Asia-Pacific region, which enhances mechanical water meters into intelligent devices [2][10] - The Cyble 5 module facilitates a transition to automated metering, helping utilities modernize infrastructure, reduce operational costs, and improve sustainability without extensive replacements [3][10] Product Details - Production of the Cyble 5 module will commence in Q4 2025 at PT Mecoindo in Cikarang, Indonesia [4] - The module includes leak detection capabilities, continuous flow alarms, and hourly data collection, which are crucial for water conservation, especially in warmer climates like Australia and New Zealand [4][5] Market Context - Itron has successfully deployed over 2 million Cyble 5 modules in the EMEA region, with positive outcomes such as reduced water losses reported by utilities like Severn Trent Water [6][10] - The introduction of Cyble 5 in Asia-Pacific is expected to yield similar benefits for local utilities [6] Innovation and Growth - Itron's recent product innovations include the Solar Battery Access Point, set to improve connectivity in areas lacking traditional networks, and the IntelliFLEX energy management system, which optimizes grid capacity [7][8] - For Q2, Itron anticipates revenues between $605 million and $615 million, with non-GAAP EPS projected to be $1.30–$1.40, reflecting a 12% year-over-year increase at the midpoint [8] Stock Performance - Itron currently holds a Zacks Rank 3 (Hold) and has seen a stock price increase of 14.2% over the past year, outperforming the Zacks Electronics - Testing Equipment industry's growth of 0.8% [9]
Julie R. Smith Named Metiri Group CEO
Prnewswire· 2025-06-06 17:18
Smith to Lead New Era of Client-Centered GrowthGENEVA, Ill., June 9, 2025 /PRNewswire/ -- Metiri Group, a leading expert and partner in environmental testing solutions, today announced the appointment of Julie R. Smith as Chief Executive Officer, effective immediately. Smith has served as interim CEO since October 2024. She takes over from Cabot Earle, who now serves as Metiri Group's Founder & Chief Strategy Officer, leading the company's M&A strategy. These leadership changes complete Metiri Group's Execu ...
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership
Globenewswire· 2025-06-05 12:45
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that Omega Laboratories Inc. of Ohio, USA (“Omega Laboratories” or “Omega”) a leading drug testing laboratory renowned for its comprehensive services has delivered a Validation Packet for Omega’s Laboratory Developed Test Method to test delta9 THC analytes in relation to the Cannabix Marijuana Breath Test (“MBT”) technology (Figure 1). Th ...
GeneDx (WGS) 2025 Conference Transcript
2025-06-04 14:55
GeneDx (WGS) 2025 Conference June 04, 2025 09:55 AM ET Speaker0 Good. Good morning. I'm Tycho Peterson from the Life Science Tools Diagnostics team. It's my pleasure to introduce our next company this morning, GeneDx. Before we jump into Q and A, going turn it over to Katherine to introduce some media. Speaker1 Wonderful. Well, thank you so much, Tycho. Thank you to the entire Jefferies team. Coming out of another busy ASCO news cycle, I'm happy to turn everyone's attention to another really important area ...
Neogen (NEOG) FY Conference Transcript
2025-06-04 14:40
Neogen (NEOG) FY Conference June 04, 2025 09:40 AM ET Speaker0 Good morning, everyone. Thank you for joining us here. My name is Brandon Vasquez. I am the research analyst here at William Blair covering Neogen. I am required to inform you that for a complete list of disclosures, please go to our website at WilliamBlair.com. Happy to have CFO and COO Dave Namora with us from Neogen this morning who's gonna present. We he will go over presentation if we have a couple minutes. Like usual, I'll ask a couple que ...
UL Solutions (ULS) FY Conference Transcript
2025-06-03 20:00
Summary of UL Solutions (ULS) FY Conference Call Company Overview - **Company**: UL Solutions (ULS) - **Industry**: Testing, Inspection, and Certification (TIC) - **Revenue**: $2.9 billion in the last fiscal year - **Customer Base**: Over 80,000 customers across more than 35 industries - **Global Presence**: 41% of revenue from the USA, 25% from Greater China, and the remainder from Europe, the Middle East, and the rest of Asia [12][18][22] Key Themes and Core Messages 1. **Mission-Driven Growth**: ULS emphasizes its mission of creating a safer world, which resonates with customers and their end-users [6][61] 2. **Safety Science Commitment**: The company focuses on applying safety science to help customers navigate challenges in innovation, security, and sustainability [7][62] 3. **Long-Term Customer Relationships**: ULS has a history of long-lived customer relationships, with many clients being with the company for over a century [8][62] 4. **Global Scale and Operating Leverage**: The company leverages its global scale to drive margin expansion and growth, having invested over $1.3 billion in acquisitions since 2010 [9][17] 5. **Financial Strength**: ULS maintains a healthy balance sheet and disciplined capital allocation, allowing for flexibility in growth strategies and shareholder returns [9][10] Market Dynamics - **Industry Size**: The TIC industry is valued at over $240 billion, with a significant portion being outsourced [17] - **Growth Drivers**: Key megatrends driving growth include energy transition, new mobility solutions, sustainability, digitalization, and regulatory compliance [20][22] - **Recurring Revenue**: 33% of ULS's revenue is recurring, stemming from ongoing certification services [15] Financial Performance and Projections - **EBITDA Margin**: The adjusted EBITDA margin was 22.9% last year, with a target of 24% for the current year [38][39] - **Growth Resilience**: ULS has demonstrated resilient growth, averaging nearly 7% compound annual growth over the past decade, even during economic shocks [33] Strategic Initiatives 1. **Capital Allocation**: ULS reinvests approximately 18% of revenue back into the business, focusing on organic growth and capacity expansion [46][48] 2. **M&A Strategy**: The company seeks acquisitions that enhance its capabilities in product testing, inspection, and certification, focusing on technical expertise and service extension [49][50] 3. **Software and Advisory Services**: ULS is optimistic about growth in its software segment, which supports product compliance and supply chain transparency [52][53] Additional Insights - **Impact of Tariffs**: ULS views tariffs as short-term challenges that can lead to increased demand for retesting and recertification services as manufacturers adapt [29][30] - **Energy Transition**: The electrification of various sectors is expected to significantly increase demand for ULS's services, particularly in testing and certification for new energy technologies [24][26] This summary encapsulates the key points discussed during the UL Solutions FY Conference Call, highlighting the company's strategic focus, market dynamics, and financial performance.